Talis Biomedical Corp

TLIS

Talis Biomedical Corp

TLIS

Insider Sentiment (TTM):

Last Purchase:2024-09-06Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2024-09-30Institutional Shares Owned:248,849Shares Outstanding:1,822,422Institutional Ownership Pct.:13.65%

Earnings Market Reaction:

Filing Date:2024-08-19Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
Series1 Convertible Preferred Stock	0	0	0	0	-30	30	0	0	0	30	0	0
Assets
Cash And Cash Equivalents At Carrying Value	60	70	77	88	98	113	130	144	165	188	233	274
Restricted Cash Current	-	-	-	-	1	1	-	-	0	0	-	-
Accounts And Other Receivables Net Current	0	0	0	0	1	0	0	0	1	3	0	-
Assets Current
Assets Current	64	71	78	90	102	116	133	150	174	201	236	278
Inventory Net	-	-	-	-	-	-	-	2	2	3	-	-
Prepaid Expense And Other Assets Current	4	1	1	2	2	1	3	4	6	7	3	3
Grants Receivable Current	-	-	-	-	-	-	-	-	-	-	0	-
Property Plant And Equipment Net	0	2	3	3	4	4	3	7	10	11	11	10
Operating Lease Right Of Use Asset	8	8	12	13	16	12	31	35	36	13	13	13
Other Assets Noncurrent	1	2	2	2	2	2	2	2	2	6	6	2
Assets	73	82	95	107	123	133	169	194	222	231	266	303
Liabilities And Stockhold…
Accounts Payable Current	4	4	1	3	2	4	4	4	4	5	5	5
Liabilities Current
Accrued Liabilities Current	1	1	1	1	1	2	1	1	3	3	6	18
Liabilities Current	8	9	9	8	9	11	13	11	14	15	19	31
Operating Lease Liability Current	3	3	3	3	3	3	4	3	2	2	1	1
Operating Lease Liability Noncurrent	16	16	17	17	18	12	30	30	31	13	13	13
Liabilities	24	26	26	26	27	23	43	42	45	28	32	44
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Additional Paid In Capital Common Stock	610	610	609	608	607	606	605	603	602	601	599	595
Stockholders Equity	49	57	69	82	96	110	127	152	177	203	234	259
Retained Earnings Accumulated Deficit	-562	-553	-540	-527	-511	-496	-478	-451	-425	-398	-365	-336
Liabilities And Stockholders Equity	73	82	95	107	123	133	169	194	222	231	266	303
Convertible Preferred Stock	-	0	0	0	0	30	0	0	0	30	0	0
Series One Convertible Preferred Stock	0	30	0	0	0	30	0	0	0	30	0	0
Temporary Equity Liquidation Preference	-	-	-	-	-	-	-	-	-	-	-	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock No Par Value	-	-	-	-	-	-	-	-	-	-	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	2	2	2	2	2	2	2	2	2	2	2	2
Shares Outstanding	2	2	2	2	2	2	2	2	2	2	2	2
Preferred Stock Shares Authorized	-	-	-	-	-	-	-	-	-	-	170	170
Preferred Stock Shares Issued	-	-	-	-	-	-	-	-	-	-	-	30
Preferred Stock Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	30

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2024	-0.11%	-5.95%	-9.55%	-64.40%	-61.22%	-58.96%	-	-	-	-	-	-
2023	-4.93%	-6.87%	-2.86%	-20.69%	-23.98%	-42.56%	12.25%	15.21%	6.20%	1.71%	2.63%	1.83%
2022	-12.71%	-29.24%	-33.05%	22.70%	-8.38%	-13.35%	-18.81%	-30.43%	-9.45%	-13.70%	-15.30%	-6.15%
2021	-	-	-	-	-	-	-18.49%	-30.46%	-48.32%	-20.71%	-35.50%	-39.05%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
Liquidity Ratios
Current Ratio	7.76	7.51	8.86	10.60	11.01	10.34	10.52	13.22	12.51	13.15	12.36	8.86
Quick Ratio	7.30	7.43	8.75	10.41	10.77	10.21	10.30	12.67	11.94	12.45	12.18	8.77
Working Capital	55.41M	61.70M	68.91M	81.08M	92.70M	104.41M	120.61M	139.00M	160.06M	185.55M	217.01M	246.22M
Leverage & Debt
Debt to Equity	0.50	0.46	0.37	0.31	0.28	0.21	0.34	0.27	0.25	0.14	0.14	0.17
Debt Ratio	0.33	0.31	0.27	0.24	0.22	0.17	0.25	0.21	0.20	0.12	0.12	0.15
Efficiency & Turnover
Asset Turnover TTM	0.00	0.01	0.02	0.01	0.02	0.02	0.02	0.02	0.02	0.01	0.03	-
Per Share Metrics
Diluted EPS TTM	-28.00	-31.40	-34.12	-41.49	-47.22	-53.95	-62.77	-63.69	-70.65	-93.23	-127.08	-
Free Cash Flow Per Share TTM	-22.18	-24.07	-29.66	-30.81	-36.61	-40.81	-56.51	-72.10	-102.09	-110.64	-115.31	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Margin Metrics
Gross Profit Margin TTM	-	97.27%	98.08%	-7.70%	-26.05%	-72.00%	-74.38%	-	-	-	-	-
Operating Profit Margin TTM	-13,510.29%	-6,262.39%	-3,130.97%	-3,664.48%	-3,165.74%	-3,558.53%	-2,392.75%	-2,134.60%	-2,630.30%	-3,750.30%	-2,341.22%	-
Net Profit Margin TTM	-12,506.37%	-5,784.73%	-2,905.67%	-3,436.98%	-3,008.94%	-3,439.75%	-2,348.55%	-2,119.66%	-2,629.45%	-3,757.88%	-2,343.90%	-
Growth Metrics
Net Revenue Growth (1Y)	-85.69%	-65.21%	-55.65%	-59.43%	-41.01%	-35.09%	-41.27%	-	-	-	-	-
Net Income Growth (1Y)	-40.54%	-41.50%	-45.13%	-34.22%	-32.50%	-40.59%	-41.15%	-	-	-	-	-
EPS Growth (1Y)	-40.71%	-41.80%	-45.65%	-34.86%	-33.16%	-42.14%	-50.61%	-	-	-	-	-
Calculated Values
Free Cash Flow TTM	-40.42M	-43.85M	-53.91M	-56.05M	-66.52M	-73.98M	-101.75M	-129.89M	-183.71M	-195.33M	-174.25M	-
Net Debt	-60.63M	-70.34M	-78.27M	-89.54M	-100.75M	-115.51M	-131.97M	-145.56M	-167.15M	-189.36M	-233.31M	-274.37M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-09-06Purchase

Owner: Leonard, Braden Michael

Title: -

Shares: 25,000

Price/Share: $1.48

Value: $37,000.00

Shares Owned: 248,702

Relationship: TenPercentOwner

Ownership: Indirect

2024-09-03Purchase

Owner: Leonard, Braden Michael

Title: -

Shares: 500

Price/Share: $4.00

Value: $2,000.00

Shares Owned: 218,602

Relationship: TenPercentOwner

Ownership: Indirect

2024-08-30Purchase

Owner: Leonard, Braden Michael

Title: -

Shares: 151

Price/Share: $4.25

Value: $641.75

Shares Owned: 218,602

Relationship: TenPercentOwner

Ownership: Indirect

2024-08-28Purchase

Owner: Leonard, Braden Michael

Title: -

Shares: 1,215

Price/Share: $3.96

Value: $4,811.40

Shares Owned: 217,951

Relationship: TenPercentOwner

Ownership: Indirect

2021-11-18Purchase

Owner: Baker, Bros. Advisors Lp,…

Title: -

Shares: 50,000

Price/Share: $4.37

Value: $218,500.00

Shares Owned: 7,053,176

Relationship: Director,TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-09-06	Leonard, Braden Michael	TenPercentOwner	-	Indirect	Purchase	25,000	1.48	$37,000.00	248,702	4
2024-09-03	Leonard, Braden Michael	TenPercentOwner	-	Indirect	Purchase	500	4.00	$2,000.00	218,602	4
2024-08-30	Leonard, Braden Michael	TenPercentOwner	-	Indirect	Purchase	151	4.25	$641.75	218,602	4
2024-08-28	Leonard, Braden Michael	TenPercentOwner	-	Indirect	Purchase	1,215	3.96	$4,811.40	217,951	4
2021-11-18	Baker, Bros. Advisors Lp,…	Director,TenPercentOwner	-	Indirect	Purchase	50,000	4.37	$218,500.00	7,053,176	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2024-09-30

13.65%

Inst. Shares: 248,849

Shares Outstanding: 1,822,422

2024-06-30

43.32%

Inst. Shares: 789,493

Shares Outstanding: 1,822,422

2024-03-31

42.93%

Inst. Shares: 782,237

Shares Outstanding: 1,822,050

2023-12-31

43.83%

Inst. Shares: 796,612

Shares Outstanding: 1,817,506

2023-09-30

40.73%

Inst. Shares: 740,876

Shares Outstanding: 1,819,066

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2024-09-30	248,849	1,822,422	13.65%
2024-06-30	789,493	1,822,422	43.32%
2024-03-31	782,237	1,822,050	42.93%
2023-12-31	796,612	1,817,506	43.83%
2023-09-30	740,876	1,819,066	40.73%
2023-06-30	3,293,526	1,817,288	181.23%
2023-03-31	11,462,345	1,812,723	-
2022-12-31	12,185,862	1,800,447	-
2022-09-30	12,597,745	1,801,391	-
2022-06-30	14,899,849	1,799,559	-
2022-03-31	16,714,536	1,765,426	-
2021-12-31	17,491,471	1,511,111	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Talis Biomedical Corp (TLIS) — SEC Financial Statements & Analysis

Talis Biomedical Corp (TLIS) is a laboratory analytical instruments company, incorporated in DE. Talis Biomedical Corp trades on OTC as: TLIS. Based on its latest SEC filing (Form 10-Q, period ending 2024-06-30), Talis Biomedical Corp reported a -85.69% year-over-year revenue growth, a Gross Profit Margin of 97.27% (TTM), a Debt-to-Equity ratio of 0.50x. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -85.69%
Gross Profit Margin TTM: 97.27%
Debt To Equity: 0.50x

Data as of 2024-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Talis Biomedical Corp in?

Talis Biomedical Corp (TLIS) operates in the Laboratory Analytical Instruments industry.

What exchange does TLIS trade on?

Talis Biomedical Corp (TLIS) trades on the OTC.

Where is Talis Biomedical Corp incorporated?

Talis Biomedical Corp is incorporated in DE.